SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-23-001715
Filing Date
2023-05-05
Accepted
2023-05-05 16:08:00
Documents
37
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk2329583.htm   iXBRL 10-Q 606818
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 14093
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 14154
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5168
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5621
  Complete submission text file 0001178913-23-001715.txt   2936652

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE entx-20230331.xsd EX-101.SCH 48439
7 XBRL CALCULATION FILE entx-20230331_cal.xml EX-101.CAL 28547
8 XBRL DEFINITION FILE entx-20230331_def.xml EX-101.DEF 52481
9 XBRL LABEL FILE entx-20230331_lab.xml EX-101.LAB 740191
10 XBRL PRESENTATION FILE entx-20230331_pre.xml EX-101.PRE 140020
31 EXTRACTED XBRL INSTANCE DOCUMENT zk2329583_htm.xml XML 163716
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38556 | Film No.: 23893845
SIC: 2836 Biological Products, (No Diagnostic Substances)